Physiologic Evidence for High-Frequency Chest Wall Oscillation and Positive Expiratory Pressure Breathing in Hospitalized Subjects With Cystic Fibrosis.

Slides:



Advertisements
Similar presentations
Pulmonary Function Testing
Advertisements

Scintigraphic Assessment of Radio-Aerosol Pulmonary Deposition With the Acapella Positive Expiratory Pressure Device and Various Nebulizer Configurations.
Presented by Mehrzad Bahtouee, MD Internist, Pulmonologist Assistant Professor of Internal Medicine Boushehr University of Medical sciences.
HFCWO and CF Is it Worth it?. Uses To loosen thick secretions that would otherwise remain in the lung Primarily indicated for Cystic Fibrosis patients.
Resting Lung Volumes An Introduction to Spirometry.
Physiology Lab Spirometry
Chapter 40 Airway Clearance Therapy
Clinical Significance
Biphasic cuirass ventilation Identification BCVWhy?Who?How?Where?When?
Respiratory Volumes Used to assess a person’s respiratory status
Cystic Fibrosis and Physiotherapy Linda Lapointe P.T. CHEO March 3 rd, 2015.
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc. Chapter 19 Pulmonary Function Testing.
2005 PPC Lectures Series: Pulmonary Function Tests Kimberly Otsuka, M.D. Pediatric Pulmonary Fellow September 19, 2005.
Figure 4. (A) a mild responder, (B) a moderate responder, and (C) a severe responder. The top panels display the arterial blood gas measurements which.
The Respiratory System: Pulmonary Ventilation
RESPIRATION Dr. Zainab H.H Dept. of Physiology Lec.5,6.
Respiratory system. The primary function of the respiratory system is the supply of oxygen to the blood and the removal of carbon dioxide.
Arm Exercise and Hyperinflation in Patients with COPD: Effect of Arm Training BACKGROUND: Unlike studies on leg exercise, reports on the regulation of.
Respiratory Function, Breathing, Respiration
Approach to bronchiectasis
Respiratory Fitness Ashlea Lockett, Nicky Gilchrist & Jenna Cruickshank.
Dr Chaitanya Vemuri Int.Med M.D Trainee.  The choice of ventilator settings – guided by clearly defined therapeutic end points.  In most of cases :
Respiratory Function Tests Fiona Gilmour SHO 03/06/04.
1 Mosby items and derived items © 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 3 Pulmonary Function Study Assessments Pulmonary Function.
Without reference, identify principles about volume/pressure and high frequency ventilators with at least 70 percent accuracy.
Interference with Ventilation Oxygen Therapy Indications: Indications: Treat: Respiratory; CV; CNS disturbances Treat: Respiratory; CV; CNS disturbances.
1 © 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license.
Effect of different cycling off criteria and positive end-expiratory pressure during pressure support ventilation in patients with chronic obstructive.
PULMONARY FUNCTION MEASUREMENTS MODULE D. Objectives At the completion of this module you will: List the four lung volumes including the following information:
Lung Mechanics Lung Compliance (C) Airway Resistance (R)
Respiratory complications of obesity. Obesity has significant effects upon the pulmonary mechanics. BMI has a direct relationship with the degree of airways.
Respiratory Function, Breathing, Respiration BI 233 Exercise 40.
Lung Function Tests Normal and abnormal Prof. J. Hanacek, MD, PhD.
TEMPLATE DESIGN © Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to COPD.
Normal and abnormal Prof. J. Hanacek, MD, PhD
Pandemic [H1N1] 2009 RT Education Module 2 Lung Protection.
1 Pulmonary Function Tests J.B. Handler, M.D. Physician Assistant Program University of New England.
Pulmonary Function David Zanghi M.S., MBA, ATC/L, CSCS.
Pulmonary Function Testing (PFT)
นพ. ธรรมศักดิ์ ทวิช ศรี หน่วยเวชบำบัด วิกฤต ฝ่ายวิสัญญีวิทยา รพ. จุฬาลงกรณ์
Pulmonary Function Measurements
Pulmonary Function Tests Cori Daines, M.D. October 6, 2009.
Spirometry A. H. Mehrparvar, MD Occupational Medicine department Yazd University of Medical Sciences.
HS 4 Respiratory Care.
An Overview of Pulmonary Function Tests Norah Khathlan M.D. Consultant Pediatric Intensivist 10/2007.
. Exercise testing in survivors of intensive care— is there a role for cardiopulmonary exercise training? Benington S, McWilliams D, Eddleston J, Atkinson.
Pulmonary Function Tests (PFTs)
Exacerbations. Exacerbations An exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond.
Figure 4. Oleic Acid Injury mechanics and ABG results. (A) a mild responder, (B) a moderate responder, and (C) a severe responder. Solid lines indicate.
Respiratory Function Tests RFTs. Review Of Anatomy & physiology Lungs comprised of  Airways  Alveoli.
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
3 nd LECTURE VENTILATORS Part One. Ventilators One of the major life support systems. Ventilators take over the vital role of the respiratory muscles.
SPIROMETRY (Pulmonary Function Testing)
Dr. Taj. What is Spirometry ? It is a measurement of the breathing capacity of the lungs. It is the most basic and frequently performed test of pulmonary.
Clinical Application of Pulmonary Function Tests Sevda Özdoğan MD, Prof. Chest Diseases.
L U N G COMPLIANCE ? Physiology Unit.
The Spirometry 1 Dr Mazen Qusaibaty MD, DIS / Head Pulmonary and Internist Department Ibnalnafisse Hospital Ministry of Syrian health –
INTERNATIONAL STUDY: USE OF HIGH FREQUENCY CHEST WALL OSCILLATION (HFCWO) IN SECRETION MANAGEMENT IN MECHANICALLY VENTILATED PATIENT. Antonio.
PRESSURE CONTROL VENTILATION
Measurement of Lung Function
Pulmonary Function Tests Pulmonary Function Tests Marcus A. Nesbeth PA-C June 19, 2009.
Rusu Gabriel- General Medicine.  Major interventions significantly affects the functions of more systems such as respiratory one, increasing the risk.
Monika Fagevik Olsén, Louise Lannefors, Elisabeth Westerdahl 
Lung function in health and disease
Management of Pulmonary Conditions
Airway Clearance Therapy With Devices and Mechanism of Action in People With Cystic Fibrosis Lisa Monchil, RRT-NPS, CCRC, AE-C New York Medical College/
Kyrgyz State Medical Academy
You could ventilate a patient
Spirometry A. H. Mehrparvar, MD Occupational Medicine department
Presentation transcript:

Physiologic Evidence for High-Frequency Chest Wall Oscillation and Positive Expiratory Pressure Breathing in Hospitalized Subjects With Cystic Fibrosis Darbee JC, Kanga JF, Ohtake PJ. Phys Ther. 2005;85(12): To examine the physiologic effects of HFCWO and PEP breathing on: –Ventilation Distribution –Gas Mixing –Lung Volume –Expiratory Airflow –Arterial Blood Oxyhemoglobin Saturation (SpO 2 ) Figure 1 Vest airway clearance system used to deliver high- frequency chest wall oscillations. Cystic fibrosis (CF) is the most common lethal inherited disease in Caucasians The effective loosening and removal of mucus are crucial to enhanced life expectancy. Complications associated with CF include: –Ventilation-perfusion mismatching –Hypoxemia –Pulmonary Hypertension –Respiratory Failure Respiratory failure accounts for greater than 80% of CF- related deaths in the US –Airway clearance techniques (ACTs) are critical components to caring for people with CF Background AbstractMethods Significant Findings: Pulmonary Function –FVC– improvements shown for both ACTs during acute stage of exacerbation only –FEV 1 – improvements shown for both ACTs during both acute and subacute stages of exacerbation Ventilation Distribution and Gas Mixing –Improvements for both ACTs in both stages of exacerbation Percent Oxygen Saturation –HFCWO– SpO 2 decreased during treatment at both admission and discharge; SpO 2 immediately returned to pretreatment measures once treatment ceased –PEP breathing– SpO 2 increased during treatment at both admission and discharge; increases in SpO 2 measures were not sustained once treatment ceased Different mechanisms led to improved ventilation distribution and gas mixing HFCWO ‒ Pendelluft– the movement of air between neighboring lung units. ‒ In obstructive lung diseases, such as CF, parallel lung units frequently fill and empty at different rates, which impairs gas mixing and exchange. ‒ Although the exact mechanism of action for improving gas mixing and ultimately ventilation distribution is speculative, one postulate is that it increases pendelluft. PEP breathing ‒ PEP breathing allows for prolonged dilation of peripheral airways and facilitates the ongoing exhalation of residual volume gas. ‒ This decreases the partial or complete obstruction of smaller peripheral airways. The role of sputum collection in studies of airway clearance treatments Sputum was not collected because within the context of repeated pulmonary function testing and airway clearance treatment interventions sputum measures reflect only the efficacy of an ACT. The authors conclude that sputum measures are not as physiologically meaningful as the other variables that they measured. Limitations of the study The bronchodilator albuterol was used during both ACTs. Albuterol absorption could have been altered by PEP breathing, which might have affected results. A previous study of similar nature showed, however, that there were not differences in total drug dosages with PEP breathing and without PEP breathing. Conclusion Guiding clinical decision making Possibility of Desaturation– Since HFCWO and PEP are similarly efficacious in increasing respiratory function, it would be more advantageous for the patient with low pretreatment SpO 2 to undergo PEP breathing because it is associated with modest increases in SpO 2 during treatment; this is contrasted with HFCWO, which was associated with decreases in SpO 2 during treatment. Results Subjects / Experimental Protocol: Fifteen subjects who were admitted to University of Kentucky Medical Center Hospital performed single-breath inert gas tests and spirometry before and immediately after HFCWO and PEP breathing on 4 separate days: Acute–2 days within 48 hours of admission Subacute—2 days within 48 hours of hospital discharge Arterial blood oxyhemoglobin saturation was monitored throughout each treatment. Interventions: Participants inhaled an aerosolized solution of albuterol prior to both ACTs to duplicate treatments routinely performed during hospitalizations and at home. HFCWO A Hill-Rom model 103 Vest airway clearance system was used Parameters: –Oscillation frequency–10 Hz for first 15 minutes –Oscillation frequency–15 Hz for last 15 minutes –Oscillations controlled by participants Procedure: –Off-cycle–inhaled to total lung capacity (TLC), activated oscillations, and then performed forced expiratory maneuver to low lung volume, which resulted in coughing and clearing of secretions. –This cycle was repeated every 5 minutes for a total of 6 cycles. PEP Breathing Participants breathed through a face mask fitted with a 1-way valve, an expiratory resistor, and a pressure manometer Parameters: –10-20 cm H 2 O was maintained during expiration Procedure: –Participants breathed against expiratory resistance for 8 breaths, removed the mask, and performed a forced expiratory maneuver to a low lung volume, which resulted in coughing and clearing of the airway secretions. –A total of 8-10 cycles of 8 breaths were performed over 30 minutes. Measurements: Single-breath Inert Gas Test–measured distribution of ventilation and gas mixing; expressed by a single breath nitrogen washout curve. Spirometry– measured vital capacity (FVC), forced expiratory volume in one second (FEV 1 ), and forced expiratory flow between 25% and 75% of vital capacity (FEF 25%-75% ); expressed as percentages of predicted values. Noninvasive Pulse Oximetry–estimated SpO 2 Data Analysis: Power analysis –15 subjects per treatment group were required to produce a large effect size, alpha level =.05 Descriptive Statistics–calculated for demographic data, percentages of distribution of ventilation, gas mixing, percentages of predicted forced vital capacity and expiratory flow measurements, and SpO 2 at study enrollment; expressed as group means and standard deviations 3-way ANOVA– calculated to determine acute changes during treatment sessions and differences in treatment at hospital admission and discharge; time and hospital status were repeated variables Post Hoc Study–conducted to identify specific differences Discussion Clinical Significance Summary Main E, Prasad A, van der Schans CP. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database of Systematic Reviews. 2005; 1:CD This systematic review analyzed articles that compared conventional chest physical therapy (CCPT) with other airway clearance techniques, including PEP breathing and HFCWO. Purpose To compare CCPT with other ACTs and their effects on respiratory function, patient preference, adherence to techniques, quality of life measures, and other outcomes. Conclusion The compiled data indicated that lung function improved irrespective of treatment type for patients with acute CF exacerbations. Relationship to Original Article This supports the original article, which found that HFCWO and PEP breathing were effective at improving pulmonary function. Article #3 and Evidence Morrison L, Agnew J. Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews. 2009;1:CD This systematic review compared the ability of various oscillating devices or techniques, compared with other forms of chest physical therapy, to improve respiratory function, mucus clearance, and other outcomes in patients with CF. Purpose To identify whether oscillatory devices, intra- or extra-thoracic (HFWCO), are effective at clearing mucus from the airways and whether they are equivalent or superior to other forms of ACT (PEP or conventional chest PT) in managing the needs of patients with CF. Conclusion Improvements in outcome measures were demonstrated regardless of the technique that was used, and there were not significant differences between techniques. Relationship to Original Article This directly supports the original article, which reported that both HFCWO and PEP breathing were effective at improving pulmonary function. PEP breathing and HFCWO are both effective at improving respiratory function in patients with CF who are experiencing acute exacerbations. This combined research is relevant to physical therapy because it is important to consider the patient’s preference and independence when performing an airway clearance technique. Techniques such as PEP breathing and HFCWO allow patients to self-administer treatments, which may improve patient compliance and also be more cost-effective than conventional chest PT, which must be administered by a professional. Physical therapists can use the above research to guide clinical decision making based on the acuity of the patient, patient preferences, and also maintaining productivity as clinicians. Presented by: Ashlea Anthony, Student Physical Therapist, DPT Candidate Bellarmine University The most important finding was that both interventions were similarly efficacious in improving pulmonary function, ventilation distribution, and gas mixing in subjects who had CF and who were experiencing an exacerbation. These results can be applied to other patients who have moderate to severe CF and who require hospitalization because of an acute exacerbation. Article #2 and Evidence Background and Purpose. This investigation identified ventilation distribution, gas mixing, lung function, and arterial blood oxyhemoglobin saturation (Spo 2 ) physiologic responses to 2 independent airway clearance treatments, high-frequency chest wall oscillation (HFCWO) and low positive expiratory pressure (PEP) breathing, for subjects who had cystic fibrosis (CF) and who were hospitalized during acute and subacute phases of a pulmonary exacerbation. Subjects. Fifteen subjects with moderate to severe CF were included in this study. Methods. Subjects performed single- breath inert gas tests and spirometry before and immediately after HFCWO and PEP breathing at admission and discharge. Arterial blood oxyhemoglobin saturation was monitored throughout each treatment. Results. At admission and discharge, PEP breathing increased Spo 2 during treatment, whereas HFCWO decreased Spo 2 during treatment. Ventilation distribution, gas mixing, and lung function improved after HFCWO or PEP breathing. Discussion and Conclusion. High- frequency chest wall oscillation and PEP breathing are similarly efficacious in improving ventilation distribution, gas mixing, and pulmonary function in hospitalized people with CF. Because Spo 2 decreases during HFCWO, people who have moderate to severe CF and who use HFCWO should have Spo 2 monitored during an acute exacerbation.. Purpose Figure 4—Ventilation Distribution Values are means ±SDs. *=significant change between pretreatment and posttreatment values Figure 5—Gas Mixing Values are means ±SDs. *=significant change between pretreatment and posttreatment values Figure 6—Percent Arterial Blood Oxyhemoglobin Saturation Values are means ±SDs. *=significantly different from values for HFCWO-Pre, HFCWO-High, HFCWO-Post, and PEP-High. **=significantly different from values for PEP-Pre, PEP-Low, PEP-Post, and HFCWO-Low. Table 3– Lung Function at Admission and Discharge b Significant change between pretreatment and posttreatment values.